SanofiFR0000120578SANSAN
Financials
Market Cap
$131.90B5Y beta
0.48EPS (TTM)
$3.671Free Float
1.10BP/E ratio (TTM)
28.32Revenue (TTM)
$51.74BEBITDA (TTM)
$15.29BPricing
Analyst Ratings
The price target is $116.41 and the stock is covered by 27 analysts.
Buy
21
Hold
5
Sell
1
Information
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.